These compounds may interact with:
Solute carrier family 15 member 1
Potentially involved in: carcinoma; inflammatory bowel disease; hartnup disease; cryptosporidiosis; short bowel syndrome; retinitis pigmentosa 49; intraductal papillary-mucinous adenoma (ipma); psoriasis
Disease data sourced from Pharos.